Table 4. Characteristics for patients who died during IPT in Kenya, 2015–2018 (n = 14).
Variables | Frequency | Percentage |
---|---|---|
Sex | ||
Female | 5 | 35.7 |
Male | 9 | 64.3 |
County | ||
Baringo | 3 | 21.4 |
Homa_Bay | 1 | 7.14 |
Isiolo | 5 | 35.7 |
Kitui | 1 | 7.1 |
Makueni | 1 | 7.1 |
Narok | 1 | 7.1 |
Trans_Nzoia | 1 | 7.1 |
Uasin_Gishu | 1 | 7.1 |
Viral Load Results after IPT | ||
Detectable > 1000 Copies/ml | 2 | 14.3 |
LDL < 1000 Copies/ml | 1 | 7.1 |
Not Documented | 12 | 85.7 |
On Pyridoxine | ||
No | 1 | 7.1 |
Yes | 8 | 57.1 |
Not Documented | 5 | 35.7 |
IPT Prescription | ||
Monthly | 13 | 92.9 |
Every 4 months | 1 | 7.1 |
IPT–isoniazid preventive therapy; LDL–lower detectable limit